Individualized selection of insulin therapy helps achieve glycaemic control in type 1 or type 2 diabetes mellitus

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.24, Iss.5, 2008-05, pp. : 13-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Insulin glargine improves glycaemic control in type 1 and 2 diabetes

Inpharma, Vol. 1, Iss. 1458, 2004-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Economic Model of First-Line Drug Strategies to Achieve Recommended Glycaemic Control in Newly Diagnosed Type 2 Diabetes Mellitus

By Ramsdell J.W.

PharmacoEconomics, Vol. 21, Iss. 11, 2003-01 ,pp. : 819-837

Adis International

Access to resources Recommend Favorite

Insulin aspart plus insulin protamine aspart [biphasic insulin aspart 30] may improve glycaemic control in patients with type 2 diabetes mellitus

Inpharma, Vol. 1, Iss. 1628, 2008-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Amylin Replacement With Pramlintide as an Adjunct to Insulin Therapy in Type 1 and Type 2 Diabetes Mellitus: A Physiological Approach Toward Improved Metabolic Control

Current Pharmaceutical Design, Vol. 7, Iss. 14, 2001-09 ,pp. : 1353-1373

Bentham Science Publishers

Access to resources Recommend Favorite

LAF 237: improved glycaemic control in type 2 diabetes mellitus

Inpharma, Vol. 1, Iss. 1451, 2004-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite